研究论文
Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery
Alejandro Forner, Marine Gilabert, Jordi Bruix, Jean‐Luc Raoul
Hospital Clínic de Barcelona Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Universitat de Barcelona
来源Nature Reviews Clinical Oncology
年份2014
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
420
416
17
18
19
20
21
22
23
24
25
关键指标
24
被引次数 · OpenAlex
1.61
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 16%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
18
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Hepatocellular Carcinoma Treatment and Prognosis
Head and Neck Cancer Studies · Colorectal Cancer Treatments and Studies
参考文献 18
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
被引 699Thomas C. C. Yau, Vikki Tang, Tzy‐Jyun Yao · Gastroenterology · 2014
Treatment of intermediate-stage hepatocellular carcinoma
被引 466Alejandro Forner, Marine Gilabert, Jordi Bruix · Nature Reviews Clinical Oncology · 2014
Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines
被引 214Kenichi Takayasu, Shigeki Arii, Masatoshi Kudo · Journal of Hepatology · 2011
此处列出前 3 条
引用本文 24
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
被引 4,288María Reig, Alejandro Forner, Jordi Rimola · Journal of Hepatology · 2021
New concepts in the treatment of hepatocellular carcinoma
被引 107Sabrina Sidali, Eric Trépo, Olivier Sutter · United European Gastroenterology Journal · 2022
Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/β-catenin signaling
被引 74Jianxin Jiang, Chao Yu, Meiyuan Chen · Biochemical and Biophysical Research Communications · 2015
按被引量排序，此处列出前 3 条